C. Russell Trenary III - Jul 6, 2021 Form 3 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role: CEO and President, Director
Signature: /s/ Lawrence Kenyon, Attorney-in-Fact
Stock symbol: OTLK
Transactions as of: Jul 6, 2021
Transactions value $: $0
Form type: 3
Date filed: 7/8/2021, 05:24 PM
Next filing: Dec 2, 2021

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned